Hosted on MSN1mon
BMO maintains Outperform on Axalta stock with $51 target
Tuesday, BMO Capital Markets maintained their Outperform rating on Axalta Coating Systems (NYSE:AXTA) with a steady price target of $51.00. BMO Capital analysts highlighted the company's potential ...
Hosted on MSN1mon
BMO raises Travelers stock target to $297, maintains Outperform
O n Thursday, BMO Capital Markets updated its outlook on Travelers Companies Inc (NYSE:TRV), with analyst Michael Zaremski increasing the price target to $297 from the previous $275. The firm has ...
Yahoo Finance21d
BMO, Scotiabank Beat Estimates on Capital-Markets Results
(Bloomberg) -- Bank of Montreal and Bank of Nova Scotia kicked off Canadian bank earnings season with strong results from their capital-markets divisions amid an increase in trading activity.
ETF Daily News3d
BMO Capital Markets Initiates Coverage on Avidity Biosciences (NASDAQ:RNA)
BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage ...
ETF Daily News3d
BMO Capital Markets Begins Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT)
BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The brokerage issued ...
Longview News-Journal1mon
BMO Capital Markets to Host 34th Annual Global Metals, Mining & Critical Minerals Conference, Feb 23 - Feb 26
Key themes to include the impact of global events on commodities and capital markets and the evolution of the sector. "For more than 100 years, BMO has been a global leader and trusted advisor ...
Business Insider8mon
History says there's a 100% chance that US stocks will rise in the second half of the year — here are 15 stocks to target for maximum gains
The S&P 500 has never lost ground in the back half of the year after advancing between 10% and 15% in the first six months, according to BMO Capital Markets, citing data since 1950. The Montreal ...
Yahoo Finance6d
BMO Capital Initiates Coverage on Dyne Therapeutics With Outperform Rating
BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...
Okta price target raised to $130 from $105 at BMO Capital
BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...
Business Insider7d
Dyne Therapeutics initiated with an Outperform at BMO Capital
BMO Capital analyst Kostas Biliouris initiated coverage of Dyne Therapeutics (DYN) with an Outperform rating and $50 price target The firm says Dyne leverages TfR1-targeted delivery for ...
Investing6d
BMO CAPITAL INITIATES AVIDITY BIOSCIENCES WITH OUTPERFORM RATING
On Tuesday, BMO Capital Markets began coverage of Avidity Biosciences (NASDAQ:RNA) shares, assigning an Outperform rating and setting a price target of $72.00. Currently trading at $29.58, the stock ...